Lasting immune memory against hepatitis B following challenge 10-11 years after primary vaccination with either three doses of hexavalent DTPa-HBV-IPV/Hib or monovalent hepatitis B vaccine at 3, 5 and 11-12 months of age.
about
Immunological persistence in 5 y olds previously vaccinated with hexavalent DTPa-HBV-IPV/Hib at 3, 5, and 11 months of age.Persistence of antibodies 20 y after vaccination with a combined hepatitis A and B vaccine.Effectiveness of hepatitis B virus vaccination program in Egypt: Multicenter national project.The immunogenicity of GSK's recombinant hepatitis B vaccine in children: a systematic review of 30 years of experience.Immunogenicity and safety of 3-dose primary vaccination with combined DTPa-HBV-IPV/Hib in Indian infants.The immunogenicity and safety of a Hib-MenAC vaccine: a non-inferiority randomized, observer-blind trial in infants aged 3-5 months.Analyzed immunogenicity of fractional doses of Sabin-inactivated poliovirus vaccine (sIPV) with intradermal delivery in rats.Lasting immune memory against hepatitis B in 12-13-year-old adolescents previously vaccinated with 4 doses of hexavalent DTPa-HBV-IPV/Hib vaccine in infancy.Persistence of hepatitis B immune memory until 9-10 years of age following hepatitis B vaccination at birth and DTaP-IPV-HB-PRP∼T vaccination at 2, 4 and 6 months.Immune Persistence After Infant Hepatitis-B Vaccination: A Systematic Review and Meta-Analysis
P2860
Q33723540-60A0F2E3-CAA5-4972-8D43-711D6081963FQ33724413-6EF33731-EA02-4B9F-897C-F271A2B24E1AQ36138640-BA988E93-1D21-4889-B7DF-A3E633BBADF9Q38674210-14954EBE-F3F8-4A08-A306-CB6652273AF8Q40088776-6BFF6151-D8D0-4718-AFA4-7231DFAC4E95Q40300059-784356EA-C28B-457D-9882-CB945296F067Q40563756-6DA89C1E-C76C-4C37-933C-E84525C013FCQ40571700-78546DB3-08DF-402F-B717-454F552C791AQ50047495-B12C350B-13D8-408B-A37F-E169D370E320Q58721551-61F6BD57-53D3-43D8-9B3C-58BBBB8638ED
P2860
Lasting immune memory against hepatitis B following challenge 10-11 years after primary vaccination with either three doses of hexavalent DTPa-HBV-IPV/Hib or monovalent hepatitis B vaccine at 3, 5 and 11-12 months of age.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Lasting immune memory against ...... 3, 5 and 11-12 months of age.
@en
Lasting immune memory against ...... 3, 5 and 11-12 months of age.
@nl
type
label
Lasting immune memory against ...... 3, 5 and 11-12 months of age.
@en
Lasting immune memory against ...... 3, 5 and 11-12 months of age.
@nl
prefLabel
Lasting immune memory against ...... 3, 5 and 11-12 months of age.
@en
Lasting immune memory against ...... 3, 5 and 11-12 months of age.
@nl
P2093
P1433
P1476
Lasting immune memory against ...... 3, 5 and 11-12 months of age.
@en
P2093
Karin Hardt
Martina Kovac
Mária Avdicova
Priya D Crasta
P304
P356
10.1016/J.VACCINE.2014.06.070
P407
P577
2014-06-22T00:00:00Z